FDA Foreign Inspections User Fee Program Getting Push On The Hill
This article was originally published in The Tan Sheet
Executive Summary
The pharmaceutical industry faces an increasingly aggressive push to create user fees for manufacturing inspections.
You may also be interested in...
FDA Highlights Hands-On Approach To China Inspections In Budget Plan
The budget request targets an increase in pharmaceutical programs’ budget authority to boost the number of FDA staff focused on China’s manufacturing. The proposed $10 million increase, including $5.6 million to be allocated toward manufacturing, provides for additional inspections, educational efforts and inspectors in China.
FDA Highlights Hands-On Approach To China Inspections In Budget Plan
The budget request targets an increase in pharmaceutical programs’ budget authority to boost the number of FDA staff focused on China’s manufacturing. The proposed $10 million increase, including $5.6 million to be allocated toward manufacturing, provides for additional inspections, educational efforts and inspectors in China.
FDA Global Pharma Safety Plan Looks To Food Model
FDA seeks new authority over the international drug supply chain to support a global safety plan.